Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement

NCT00648323 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate

Interventions

DRUG: Doxazosin mysylate GITS

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.